Benchmark Initiates Coverage On Agilon Health with Buy Rating, Announces Price Target of $28
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bill Sutherland has initiated coverage on Agilon Health (NYSE:AGL) with a Buy rating and a price target of $28.
October 20, 2023 | 2:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Agilon Health has been initiated with a Buy rating by Benchmark, with a price target of $28.
The initiation of coverage by Benchmark with a Buy rating and a price target of $28 indicates a positive outlook for Agilon Health. This could potentially attract investors, driving up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100